{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:20:59Z","timestamp":1783689659425,"version":"3.55.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Abbott Medical"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The incidence of, and risk factors for, acute kidney injury (AKI) after endovascular intervention for peripheral artery disease (PAD) remain unknown. The aim of this study was to assess the proportion of patients who develop AKI and explore the risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Prospectively collected data on patients undergoing femoropopliteal endovascular intervention for symptomatic PAD across three vascular centres were analysed. The proportion of patients developing AKI (according to the Kidney Disease Improving Global Outcomes definition) within 48 h, and the proportion developing the composite Major Adverse Kidney Events (MAKE) endpoints (death, dialysis, drop in estimated glomerular filtration rate at least 25 per cent) at 30 days (MAKE30) and remains 90 days (MAKE90) were calculated. Multivariable regression analysis was used to assess predictors of AKI, and the association between AKI and death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Some 2041 patients were included in the analysis. AKI developed in 239 patients (11.7 per cent), with 47 (2.3 per cent) requiring dialysis within 30 days, and 18 (0.9 per cent) requiring ongoing dialysis. The MAKE30 and MAKE90 composite endpoints were reached in 358 (17.5 per cent) and 449 (22.0 per cent) patients respectively. Risk factors for AKI were age, sex, congestive heart failure, chronic limb-threatening ischaemia, emergency procedure, and pre-existing chronic kidney disease. AKI, dementia, congestive heart failure, and major amputation were risk factors for medium-term mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>AKI is a common complication after intervention for PAD and is associated with medium-term mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjs\/znaa057","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T04:12:50Z","timestamp":1609474370000},"page":"152-159","source":"Crossref","is-referenced-by-count":20,"title":["Acute kidney injury following endovascular intervention for peripheral artery disease"],"prefix":"10.1093","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-3910","authenticated-orcid":false,"given":"E","family":"Katsogridakis","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Centre, University of Leicester , Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lea","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS Foundation Trust , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yap","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS Foundation Trust , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Batchelder","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Centre, University of Leicester , Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS Foundation Trust , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Diamantopoulos","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS Foundation Trust , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Saratzis","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Aristotle University Medical School, Papageorgiou General Hospital , Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Centre, University of Leicester , Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zayed","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS Foundation Trust , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Bown","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Centre, University of Leicester , Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3399-094X","authenticated-orcid":false,"given":"A","family":"Saratzis","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences and National Institute for Health Research Leicester Biomedical Research Centre, University of Leicester , Leicester, UK"},{"name":"Department of Vascular Surgery, Guy\u2019s and St Thomas\u2019 Hospital NHS Foundation Trust , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2023063010492159800_znaa057-B1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"2023063010492159800_znaa057-B2","doi-asserted-by":"crossref","first-page":"j5842","DOI":"10.1136\/bmj.j5842","article-title":"Peripheral artery disease","volume":"360","author":"Morley","year":"2018","journal-title":"BMJ"},{"key":"2023063010492159800_znaa057-B3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2023063010492159800_znaa057-B4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.ajkd.2018.08.008","article-title":"Risk factors for recurrent acute kidney injury in a large population-based cohort","volume":"73","author":"Liu","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2023063010492159800_znaa057-B5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000440986","article-title":"Intervention associated acute kidney injury and long-term cardiovascular outcomes","volume":"42","author":"Saratzis","year":"2015","journal-title":"Am J Nephrol"},{"key":"2023063010492159800_znaa057-B6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejvs.2015.08.023","article-title":"Contrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease","volume":"51","author":"Sigterman","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2023063010492159800_znaa057-B7","first-page":"177","article-title":"Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary","volume":"7","author":"McCullough","year":"2006","journal-title":"Rev Cardiovasc Med"},{"key":"2023063010492159800_znaa057-B8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"Am J Med"},{"key":"2023063010492159800_znaa057-B9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ajkd.2016.05.018","article-title":"Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study","volume":"69","author":"Sawhney","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2023063010492159800_znaa057-B10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jvs.2018.06.196","article-title":"Contrast-induced nephropathy after peripheral vascular intervention: long-term renal outcome and risk factors for progressive renal dysfunction","volume":"69","author":"Al Adas","year":"2019","journal-title":"J Vasc Surg"},{"key":"2023063010492159800_znaa057-B11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jvs.2014.10.020","article-title":"The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia","volume":"61","author":"Arora","year":"2015","journal-title":"J Vasc Surg"},{"key":"2023063010492159800_znaa057-B12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0003319715603184","article-title":"Long-term mortality after invasive angiography and endovascular revascularization in patients with PAD having chronic kidney disease","volume":"67","author":"Gebauer","year":"2016","journal-title":"Angiology"},{"key":"2023063010492159800_znaa057-B13","first-page":"2058460115583034","article-title":"Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease","volume":"4","author":"Kroneberger","year":"2015","journal-title":"Acta Radiol Open"},{"key":"2023063010492159800_znaa057-B14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ccd.20316","article-title":"Renal failure after percutaneous coronary intervention is associated with high mortality","volume":"64","author":"Gupta","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"2023063010492159800_znaa057-B15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2011.05.023","article-title":"Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions","volume":"58","author":"Gurm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023063010492159800_znaa057-B16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/eurheartj\/ehu063","article-title":"Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy","volume":"35","author":"Narula","year":"2014","journal-title":"Eur Heart J"},{"key":"2023063010492159800_znaa057-B17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000363725","article-title":"Clinical trial endpoints in acute kidney injury","volume":"127","author":"Billings","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"2023063010492159800_znaa057-B18"},{"key":"2023063010492159800_znaa057-B19","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ki.2015.311","article-title":"Renal dysfunction after endovascular abdominal aortic aneurysm repair: time to use the correct outcome measures","volume":"88","author":"Saratzis","year":"2015","journal-title":"Kidney Int"},{"key":"2023063010492159800_znaa057-B20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ahj.2012.02.011","article-title":"The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)","volume":"163","author":"Slocum","year":"2012","journal-title":"Am Heart J"},{"key":"2023063010492159800_znaa057-B21","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2023063010492159800_znaa057-B22"},{"key":"2023063010492159800_znaa057-B23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2023063010492159800_znaa057-B24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","article-title":"2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023063010492159800_znaa057-B25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner","year":"2016","journal-title":"J Vasc Surg"},{"key":"2023063010492159800_znaa057-B26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"Matsushita","year":"2012","journal-title":"JAMA"},{"key":"2023063010492159800_znaa057-B27","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"2023063010492159800_znaa057-B28","doi-asserted-by":"crossref","first-page":"f4930","DOI":"10.1136\/bmj.f4930","article-title":"Acute Kidney Injury Guideline Development Group. Acute kidney injury: summary of NICE guidance","volume":"347","author":"Ftouh","year":"2013","journal-title":"BMJ"},{"key":"2023063010492159800_znaa057-B29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/bjs.11384","article-title":"Umbrella review and meta-analysis of antiplatelet therapy for peripheral artery disease","volume":"107","author":"Ambler","year":"2020","journal-title":"Br J Surg"},{"key":"2023063010492159800_znaa057-B30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"2023063010492159800_znaa057-B31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2152\/jmi.65.116","article-title":"The ratio of contrast medium volume to estimated glomerular filtration rate as a predictor of contrast-induced nephropathy after endovascular aortic repair","volume":"65","author":"Kawatani","year":"2018","journal-title":"J Med Invest"},{"key":"2023063010492159800_znaa057-B32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0003319714546527","article-title":"Long-term follow-up of patients at high risk for nephropathy after contrast exposure","volume":"66","author":"Abaci","year":"2015","journal-title":"Angiology"},{"key":"2023063010492159800_znaa057-B33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/joic.12379","article-title":"Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium","volume":"30","author":"Grossman","year":"2017","journal-title":"J Interv Cardiol"},{"key":"2023063010492159800_znaa057-B34","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.105.595090","article-title":"Contrast-induced nephropathy: a clinical and evidence-based approach","volume":"113","author":"Tepel","year":"2006","journal-title":"Circulation"},{"key":"2023063010492159800_znaa057-B35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1253\/circj.72.427","article-title":"Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration","volume":"72","author":"Shiragami","year":"2008","journal-title":"Circ J"},{"key":"2023063010492159800_znaa057-B36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejvs.2019.09.508","article-title":"Editor\u2019s choice\u2014Acute kidney injury (AKI) in aortic intervention: findings from the Midlands Aortic Renal Injury (MARI) cohort study","volume":"59","author":"Saratzis","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2023063010492159800_znaa057-B37","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2215\/CJN.04870515","article-title":"Long-term renal function after endovascular aneurysm repair","volume":"10","author":"Saratzis","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023063010492159800_znaa057-B38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/eci.12061","article-title":"Contrast-induced acute kidney injury following PCI","volume":"43","author":"Tehrani","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"2023063010492159800_znaa057-B39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/02841850802050762","article-title":"Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention","volume":"49","author":"Nyman","year":"2008","journal-title":"Acta Radiol"},{"key":"2023063010492159800_znaa057-B40","doi-asserted-by":"crossref","first-page":"496438","DOI":"10.5402\/2013\/496438","article-title":"Radiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategies","volume":"2013","author":"Sadat","year":"2013","journal-title":"ISRN Radiol"},{"key":"2023063010492159800_znaa057-B41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000430770","article-title":"Contrast medium-induced acute kidney injury","volume":"5","author":"Sadat","year":"2015","journal-title":"Cardiorenal Med"},{"key":"2023063010492159800_znaa057-B42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-2-38","article-title":"Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis","volume":"2","author":"Bagshaw","year":"2004","journal-title":"BMC Med"},{"key":"2023063010492159800_znaa057-B43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jvs.2017.03.446","article-title":"Current status of carbon dioxide angiography","volume":"66","author":"Sharafuddin","year":"2017","journal-title":"J Vasc Surg"},{"key":"2023063010492159800_znaa057-B44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40697-016-0103-z","article-title":"Acute kidney injury in the era of big data: the 15th Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"3","author":"Bagshaw","year":"2016","journal-title":"Can J Kidney Health Dis"},{"key":"2023063010492159800_znaa057-B45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ki.2012.427","article-title":"World Kidney Day Steering Committee 2013. Acute kidney injury: global health alert","volume":"83","author":"Li","year":"2013","journal-title":"Kidney Int"},{"key":"2023063010492159800_znaa057-B46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cardfail.2009.12.020","article-title":"Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: synergistic acceleration of renal dysfunction and left ventricular remodeling","volume":"16","author":"Anzai","year":"2010","journal-title":"J Card Fail"},{"key":"2023063010492159800_znaa057-B47","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1186\/cc13158","article-title":"Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study","volume":"17","author":"Hansen","year":"2013","journal-title":"Crit Care"},{"key":"2023063010492159800_znaa057-B48","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc13054","article-title":"Risk of developing severe sepsis after acute kidney injury: a population-based cohort study","volume":"17","author":"Lai","year":"2013","journal-title":"Crit Care"},{"key":"2023063010492159800_znaa057-B49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000337487","article-title":"Acute kidney injury and mortality in hospitalized patients","volume":"35","author":"Wang","year":"2012","journal-title":"Am J Nephrol"},{"key":"2023063010492159800_znaa057-B50","doi-asserted-by":"crossref","first-page":"e0121482","DOI":"10.1371\/journal.pone.0121482","article-title":"Long-term sequelae of severe acute kidney injury in the critically ill patient without comorbidity: a retrospective cohort study","volume":"10","author":"Fortrie","year":"2015","journal-title":"PLoS One"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/108\/2\/152\/50745151\/znaa057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/108\/2\/152\/50745151\/znaa057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T10:54:37Z","timestamp":1688122477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/108\/2\/152\/6099683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,3,12]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znaa057","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2021,1,15]]}}}